Watchlist Price Alert

Nautilus Biotechnology In... (NAUT)

NASDAQ: NAUT · Real-Time Price · USD

0.70

-0.00 (-0.09%)

At close: Jun 18, 2025, 3:36 PM

Nautilus Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-70.78M	-63.67M	-57.92M	-50.31M	-15.62M	-9.62M	626.6M
Depreciation & Amortization	6.35M	5.71M	3.42M	2.84M	2.35M	548K	n/a
Stock-Based Compensation	12.7M	12.14M	10.38M	7.93M	369K	110K	n/a
Other Working Capital	-4.88M	-3.61M	-227K	-1.28M	-1.51M	-545K	1.33M
Other Non-Cash Items	-1.96M	-2.66M	-890K	320K	295K	-157K	-866.23M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-5.46M	-3.22M	-788K	-22K	-1.39M	-545K	1.33M
Operating Cash Flow	-59.15M	-51.71M	-45.81M	-39.24M	-14M	-9.66M	-238.3M
Capital Expenditures	-2.12M	-2.44M	-2.32M	-2.27M	-921K	-926K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	24.36K	n/a	n/a
Purchase of Investments	-86.28M	-112.89M	-186.59M	-221.79M	-68.36M	n/a	n/a
Sales Maturities Of Investments	n/a	71.6M	163.18M	85.1M	44M	n/a	n/a
Other Investing Acitivies	154.65M	n/a	n/a	n/a	-24.36K	4.98M	1.2M
Investing Cash Flow	66.25M	-43.73M	-25.74M	-138.96M	-25.28M	4.05M	1.2M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	524K	264K	232K	n/a	n/a	-874.33K	-1.2M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.14M	368K	562K	327.45M	42K	36K	145.19B
Financial Cash Flow	1.14M	368K	562K	327.45M	75.9M	36K	145.19B
Net Cash Flow	8.25M	-95.08M	-70.98M	149.24M	36.62M	595K	1.2M
Free Cash Flow	-61.27M	-54.15M	-48.13M	-41.51M	-14.92M	-10.59M	-238.3M